• Endo Pharmaceuticals Inc., of Chadds Ford, Pa., received FDA approval of Fortesta (testosterone 2 percent gel) for low testosterone. Endo licensed the drug, which received an approvable letter in 2009, from Prostrakan Group plc. (See BioWorld Today, Aug. 27, 2009.)